August 23, 2024 05:23 PM EDTUpdated 05:45 PM

Gene editing startup Tome Biosciences to lay off almost all workers

Ryan Cross

Senior Science Correspondent

Tome Biosciences, a high-profile gene editing startup, will terminate nearly its entire workforce during the first two weeks of November.
It disclosed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Gene editing startup Tome Biosciences to lay off almost all workers

Ryan Cross

Senior Science Correspondent

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Bad trip: How culture conflict and a need for cash nearly broke Lykos

Cigna sues FTC, calling for withdrawal of 'biased, erroneous' PBM report

Novartis’ Kisqali snags FDA approval to reduce recurrence in patients with early forms of breast cancer

23andMe heads to ESMO to tout its two clinical-stage drugs after scrapping discovery team

CDMO Serán sets out to build first commercial facility, with a $200M investment led by Bain Capital

Breaking down silos with a new quantitative approach to drug development

Gene edit­ing start­up Tome Bio­sciences to lay off al­most all work­ers

Senior Science Correspondent

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Gene editing startup Tome Biosciences to lay off almost all workers